Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study

Jessica L. Maxwell, David T. Felson, Jingbo Niu, Barton Wise, Michael C. Nevitt, Jasvinder A. Singh, Laura Frey-Law and Tuhina Neogi
The Journal of Rheumatology January 2014, 41 (1) 60-64; DOI: https://doi.org/10.3899/jrheum.130313
Jessica L. Maxwell
From the Department of Physical Therapy and Athletic Training, College of Health and Rehabilitation Sciences, Boston University; Clinical Epidemiology Training Unit, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmaxwell{at}bu.edu
David T. Felson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingbo Niu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barton Wise
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C. Nevitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasvinder A. Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Frey-Law
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuhina Neogi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective. Poor functional outcomes post–knee replacement are common, but estimates of its prevalence vary, likely in part because of differences in methods used to assess function. The agreement between improvement in function and absolute good levels of function after knee replacement has not been evaluated. We evaluated the attainment of improvement in function and absolute good function after total knee replacement (TKR) and the agreement between these measures.

Methods. Using data from The Multicenter Osteoarthritis (MOST) Study, we determined the prevalence of achieving a minimal clinically important improvement (MCII, ≥ 14.2/68 point improvement) and Patient Acceptable Symptom State (PASS, ≤ 22/68 post-TKR score) on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function subscale at least 6 months after knee replacement. We also assessed the frequency of co-occurrence of the 2 outcomes, and the prevalence according to pre-knee replacement functional status.

Results. We included 228 subjects who had a knee replacement during followup (mean age 65 yrs, mean body mass index 33.4, 73% female). Seventy-one percent attained the PASS for function after knee replacement, while only 44% attained the MCII. Of the subjects who met the MCII, 93% also attained the PASS; however, of subjects who did not meet the MCII, 54% still achieved a PASS. Baseline functional status was associated with attainment of each MCII and PASS.

Conclusion. There was only partial overlap between attainment of a good level of function and actually improving by an acceptable amount. Subjects were more likely to attain an acceptable level of function than to achieve a clinically important amount of improvement post–knee replacement.

Key Indexing Terms:
  • KNEE REPLACEMENT
  • PHYSICAL FUNCTION
  • OUTCOMES

Post–total knee replacement (TKR) functional limitations such as difficulties with stair-climbing or walking occur in about 10% to 30% of patients1,2. While this may represent only a minority of persons undergoing TKR, the absolute number affected by functional limitations post-TKR is large given the volume of procedures performed. As the numbers undergoing TKR continue to rise, with an estimated 3.5 million TKR predicted to be performed annually in the United States by 2030, an increase of > 600% compared with 20053, the number of patients with poor functional outcomes will also likely rise. One difficulty in studying the effect of poor functional outcomes post-TKR is that presently no clear consensus exists as to how best to define a successful functional outcome4.

Successful functional outcomes post-TKR may be defined by either the degree of improvement or the absolute level, or status, of function post-TKR. Relative improvement from baseline to followup following specific interventions is often reported in terms of a minimal clinically important improvement (MCII). MCII is often determined using an anchor question on improvement, such as “somewhat better”; with MCII thresholds defined by how much improvement on a scale corresponds to “somewhat better” in a certain percentage of patients.

On the other hand, the absolute level, or current status, of function may be defined using a Patient Acceptable Symptom State (PASS). The PASS is determined using an anchor question about satisfaction with current symptoms or performance5, then determining the score at which a particular percentage of subjects report meeting that benchmark. MCII and PASS values are specific to the outcome measurement tool under study and any subscales existing within the tool. The 2 systems also have different values depending on the patient population and intervention received even when using the same outcome measure [e.g., MCII values for knee osteoarthritis (OA) and knee replacement will differ]5,6. There is recent evidence that MCII and PASS thresholds for pain after nonsteroidal drug use may be similar to those of several rheumatic diseases7; however, it is possible that these may differ from those for a major intervention such as surgery.

It is currently unknown whether achievement of a particular absolute level of function post-TKR is indicative of a minimal clinically important improvement, or how frequently achieving a meaningful relative improvement in function translates into an acceptable level of absolute function after surgery. While a recent study determined MCII and PASS values for persons after TKR in different patient populations8, to our knowledge there have not been studies comparing these 2 measurements in a single clinical population. Understanding the relationship between the 2 constructs will provide guidance for future research regarding the optimal definition of good functional outcomes in a TKR population.

The goals of our study were (1) to determine the prevalence of an MCII in function, and an acceptable level of absolute function post-TKR, and (2) to determine the overlap between the two and examine the prevalence of these outcomes according to pre-TKR (baseline) function in a large multicenter cohort study.

MATERIALS AND METHODS

Study sample

The Multicenter Osteoarthritis (MOST) study is a U.S. National Institutes of Health-funded longitudinal prospective cohort study of 3026 people with or at high risk of knee OA and aged 50 to 79 years at baseline, recruited from Birmingham, Alabama, and Iowa City, Iowa. Study design and subject eligibility have been described elsewhere9. The MOST study was approved by the institutional review boards at the University of Iowa; the University of Alabama, Birmingham; the University of California, San Francisco; and Boston University Medical Center.

For our study, we included subjects who had at least 1 TKR since study enrollment with a recorded date of surgery, who also had physical function data obtained at the study visit prior to TKR and a study visit at least 6 months following TKR, to allow for sufficient surgical recovery time10. Less than 3% of subjects had unicompartmental knee replacement and the rest had TKR; thus we use the term TKR to describe our sample. Data collected after revision surgeries were not included. Subjects with exposure and outcome data at each of the assessment time points were included in the analyses, irrespective of whether they developed conditions that could alter function.

Assessment of physical function

Subjects completed the self-report Western Ontario and McMaster Universities Osteoarthritis Index Physical Function11 subscale (WOMAC-PF) at baseline, 30-month, and 60-month study visits.

Assessment of TKR status

Knee replacements were self-reported at MOST clinic visits at baseline, 30 months, or 60 months, or at a telephone interview at 15 months, with > 95% confirmed by medical records and/or study knee radiographs obtained postsurgery.

Statistical methods

We used 2 measures of TKR functional outcome in this study both calculated from the WOMAC-PF: the MCII and the PASS.

We defined the minimal clinically meaningful amount of improvement from pre-TKR to post-TKR as an improvement of ≥ 14.2 out of 68 points. This value was determined by transforming the published MCII for function after knee replacement of 20.84/1006 to the raw scale of a total of 68 points for the WOMAC-PF subscale. The original authors established this threshold using the mean score of the subjects who reported feeling “somewhat better”6. We defined a level of “acceptable” absolute function post-TKR as a score of ≤ 22/68 using the PASS for post-TKR function12. This threshold was determined using the 75th percentile score of all subjects reporting that their function was acceptable. We similarly transformed this from its published value of 67.7/100 (high scores meaning better function) to a score out of 68 with high scores meaning worse function in accordance with the original WOMAC. While the thresholds were established using different percentages of subjects attaining each definition of good function, they are to date the only published MCII and PASS values for function following knee replacement.

We determined the proportion of subjects attaining the MCII and the PASS. We stratified these results by quartiles of pre-TKR function given its influence on post-TKR function13,14 and assessed between-group differences using a chi-squared test. We assessed the frequency of attaining the PASS for post-TKR function according to attainment of the MCII. We excluded subjects that had a pre-TKR functional score of ≤ 14 out of 68 from all analyses, because they were unable to attain the MCII (i.e., their pre-TKR function precluded sufficient improvement to achieve the MCII). We did not differentiate between subjects with 1 or 2 knees replaced in these analyses, or between those with both knees replaced concurrently or staged. We conducted 2 sensitivity analyses. Because of concerns that some pre-TKR subjects had their clinical visit far before their surgery and therefore deterioration in function prior to surgery may not have been recorded, we restricted our analyses of the proportion attaining the MCII to those who had their pre-TKR data assessed within 6 months of their TKR. We also conducted ad hoc analyses of the number of subjects who attained MCII after excluding those subjects who were at the PASS level pre-TKR. Statistical analyses were completed using SAS 9.1 (SAS Software).

RESULTS

There were 271 subjects with a TKR since baseline. We excluded 38 subjects (14%) with function scores too low to allow attainment of the MCII, and 5 subjects whose post-TKR study visit was within 6 months of their surgery, leaving 228 subjects in our study sample. Of these, 73 subjects had replacements in both knees (sequentially or concurrently). The majority of subjects were white and female, with a mean body mass index (BMI) in the obese range, and mean WOMAC-PF scores demonstrating moderate functional limitation (Table 1). Compared to a recent study using 2617 of the 3026 MOST participants15, the subjects in our study were older, had a higher mean BMI, and there was a higher percentage of women. The average time between the pre-TKR function assessment and date of TKR was 15.5 months (1.3 yrs); the average time between the date of TKR and first postreplacement function assessment was 21.6 months (1.8 yrs; any visit falling within 6 months of surgery was excluded).

View this table:
  • View inline
  • View popup
Table 1.

Demographic and pre-total knee replacement (TKR) clinical information of the study subjects.

Forty-four percent of subjects achieved the MCII after TKR, and seventy-one percent of subjects attained the PASS for post-TKR function (Table 2). Forty-one percent of subjects met both the MCII and PASS. Twenty-six percent met neither outcome criterion. Only 3% met the MCII but did not meet the PASS, while 30% did not meet the MCII, but did meet the PASS. Twenty-six percent of subjects had baseline (pre-TKR) function scores at or better than the PASS for TKR function. When the analysis was repeated after excluding these subjects, the proportion that attained the MCII only rose by 5% to 49%. Of the subjects who met the MCII, 93% of them also attained the PASS for post-TKR function. However, of the subjects who did not meet the MCII, 54% of them still achieved the PASS for post-TKR function.

View this table:
  • View inline
  • View popup
Table 2.

Proportion of subjects by combination of post–total knee replacement (TKR) outcomes, and demographics of each group.

Those with worse baseline function were more likely to attain an MCII (p = 0.0006), but less likely to attain the PASS for post-TKR function (p < 0.0001; Figure 1). Subjects with the best baseline function were least likely to attain an MCII (28%), but more likely to attain the PASS for post-TKR function (90%). Subjects having their TKR more closely following the pre-TKR visit had slightly worse pre-TKR function than those having the TKR more months after the visit (p = 0.02). When the analysis was restricted to those who had their pre-TKR assessment within 6 months of their surgery (n = 54), the proportion of subjects that attained the MCII rose to 63%. The number of months between pre-TKR visit and TKR was not associated with PASS attainment (OR 0.98, 95% CI 0.95–1.0), and was only weakly associated with MCII attainment (0.93, 95% CI 0.90–0.96).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Proportion of subjects attaining each measure of post–total knee replacement function by baseline function score. MCII: minimal clinically important improvement; PASS: Patient Acceptable Symptom State; KR: knee replacement; WOMAC-PF: Western Ontario and McMaster Universities Osteoarthritis Index Physical Function subscale.

DISCUSSION

Our study demonstrates that the proportion achieving an MCII after TKR is not the same as the proportion that achieved an acceptable absolute level of function. Although almost all subjects who attained an MCII also reached the threshold for good absolute function (PASS), many subjects who did not achieve an MCII also had good absolute function post-TKR.

The low proportion of subjects with minimal clinically important improvement in function post-TKR is in contrast with another study, in which 64% of subjects attained the MCII at 2 years post-TKR16. However, when we limited the analysis to those with a pre-TKR assessment of function within 6 months of the surgery, 63% attained the MCII, consistent with these prior estimates. The overall proportion achieving the PASS in our study (71%) was consistent with the reported prevalence with self-reported good function post-TKR2,17. Of particular interest is that only 41% of subjects had both a minimal clinically important improvement in function (MCII) and attained a state of acceptable physical function (PASS). Conversely, 26% of subjects did not attain either benchmark (i.e., neither attained an acceptable level of function, nor an MCII in function), supporting other findings regarding the proportion of patients who continue to report functional limitations after TKR2.

The effect of pre-TKR, or baseline, function on the prevalence of functional outcomes differed for each outcome measure. Subjects with worse pre-TKR function had greater ability to improve, thereby increasing the likelihood of attaining the MCII, but decreasing the likelihood of attaining the PASS for post-TKR function because they needed greater improvement to achieve it. The opposite was true of subjects with better TKR function. The effect of baseline score on MCII attainment has been demonstrated previously13,14,17,18; however, our study is the first, to our knowledge, to examine the relationship between relative improvement and absolute functional status after TKR. Our sensitivity analyses confirmed that the baseline score, rather than the time between pre-TKR assessment and surgery is more closely associated with attainment of a good outcome. Clinicians should consider baseline function when transmitting information on expected TKR outcomes to patients, and note that the improvement or state experienced after TKR may depend on how one defines it.

There are limitations to our study. The mean time to followup after TKR was 1.8 years. We used the MCII threshold previously published for those who are 2 years post-TKR6, and the PASS threshold from subjects 1 year following TKR12. We feel that this difference is unlikely to have affected our results, as data suggest that only minimal changes in function occur between 1 and 2 years post-TKR10,19. The values we used for the MCII and the PASS differed from published thresholds for patients with various rheumatic diseases who are taking nonsteroidal antiinflammatory therapy7. There is recent evidence suggesting that PASS values may be too low in rheumatic disease populations20. However, we used values determined specifically for TKR, and it is reasonable to expect that thresholds for pharmacologic versus surgical interventions would have different levels of acceptable response. We conducted a sensitivity analysis in which we used values at the upper and lower bounds of the 95% CI for each outcome (published in Escobar 201212 and calculated from data in Escobar 20076). This resulted in 40% to 51% of subjects meeting the MCII and 65% to 76% of subjects attaining the PASS. Both the 75% threshold and the mean for determining the MCII have been used in other studies6,7,21. If, as in the PASS, we had used the 75% threshold for MCII, then even fewer of our subjects would have met the MCII threshold and the discordance between PASS and MCII would have been greater.

In the main analysis, we did not exclude subjects whose pre-TKR function was at or above the PASS for TKR function because one of our aims was to assess the proportion with good absolute function after TKR, regardless of the degree of relative improvement. This may explain why 90% and 84% of the subjects in the best 2 quartiles of prereplacement function attained the PASS and why many fewer attained the MCII. Lastly, our analyses focused on a self-report measure of function and may not be similar to findings using performance-based measures of function.

If MCII in function is attained, an acceptable level of functioning after knee replacement is also likely to be attained. However, if MCII in function is not achieved, the likelihood of functioning at an acceptable level post-TKR depends on pre-TKR functional status. Further research is warranted on timing of surgery in relation to presurgical functional status and its effect on outcomes, as well as on understanding patient preferences regarding the importance of relative improvement in function versus absolute level of function. Insight into these concepts will be important in developing consensus regarding the optimal definition of successful functional outcomes post-TKR4, and ultimately would facilitate comparative effectiveness research for TKR.

Footnotes

  • Ms. Maxwell is supported by the American College of Rheumatology REF Research Scientist Development Award and NIDDR H133B100003-11. The MOST Study is supported by US National Institutes of Health grants: U01-AG18820, U01-AG19069, U01-AG18832, U01-AG18947. This work is also supported by AR-47785.

  • Accepted for publication September 27, 2013.

REFERENCES

  1. 1.↵
    1. Kane R,
    2. Saleh KJ,
    3. Wilt TJ,
    4. Bershadsky B
    . The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am 2005;87A:1719–24.
    OpenUrl
  2. 2.↵
    1. Singh JA,
    2. O’Byrne M,
    3. Harmsen S,
    4. Lewallen D
    . Predictors of moderate–severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage 2007;18:515–21.
    OpenUrl
  3. 3.↵
    1. Kurtz S,
    2. Ong K,
    3. Lau E,
    4. Mowat F,
    5. Halpern M
    . Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780–5.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Losina E,
    2. Katz J
    . Total TKR: pursuit of the paramount result. Rheumatology 2012;51:1735–6.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Tubach F,
    2. Ravaud P,
    3. Baron G,
    4. Falissard B,
    5. Logeart I,
    6. Bellamy N,
    7. et al.
    Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005;64:34–7.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Escobar A,
    2. Quintana JM,
    3. Bilbao A,
    4. Arostegui I,
    5. Lafuente I,
    6. Vidaurreta I
    . Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage 2007;15:273–80.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Tubach F,
    2. Ravaud P,
    3. Martin-Mola E,
    4. Awada H,
    5. Bellamy N,
    6. Bombardier C,
    7. et al.
    Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res 2012;64:1699–707.
    OpenUrlCrossRef
  8. 8.↵
    1. Perrot S,
    2. Bertin P
    . “Feeling better” or “feeling well” in usual care of hip and knee osteoarthritis pain: Determination of cutoff points for patient acceptable symptom state (PASS) and minimal clinically important improvement (MCII) at rest and on movement in a national multicenter cohort study of 2414 patients with painful osteoarthritis. Pain 2013;154:248–56.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Felson DT,
    2. Niu J,
    3. Guermazi A,
    4. Roemer F,
    5. Aliabadi P,
    6. Clancy M,
    7. et al.
    Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum 2007;56:2986–92.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Davis A,
    2. Perruccio AV,
    3. Ibrahim S,
    4. Hogg-Johnson S,
    5. Wong R,
    6. Streiner DL,
    7. et al.
    The trajectory of recovery and the inter-relationships of symptoms, activity and participation in the first year following total hip and TKR. Osteoarthritis Cartilage 2011;19:1413–21.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Bellamy N,
    2. Buchanan WW,
    3. Goldsmith CH,
    4. Campbell J,
    5. Stitt LW
    . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–40.
    OpenUrlPubMed
  12. 12.↵
    1. Escobar A,
    2. Gonzalez M,
    3. Quintana JM,
    4. Vrotsou K,
    5. Bilbao A,
    6. Herrera-Espiñeira C,
    7. et al.
    Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. Osteoarthritis Cartilage 2012;20:87–92.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Hawker G,
    2. Wright J,
    3. Coyte P,
    4. Paul J,
    5. Dittus R,
    6. Croxford R,
    7. et al.
    Health-related quality of life after TKR. J Bone Joint Surg Am 1998;80:163–73.
    OpenUrl
  14. 14.↵
    1. Fortin PR,
    2. Penrod JR,
    3. Clarke AE,
    4. St-Pierre Y,
    5. Joseph L,
    6. Bélisle P,
    7. et al.
    Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002;46:3327–30.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Felson DT,
    2. Niu J,
    3. Gross KD,
    4. Englund M,
    5. Sharma L,
    6. Cooke TD,
    7. et al.
    Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative. Arthritis Rheum 2013;65:355–62.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Tubach F,
    2. Dougados M,
    3. Falissard B,
    4. Baron G,
    5. Logeart I,
    6. Ravaud P
    . Feeling good rather than feeling better matters more to patients. Arthritis Care Res 2006;55:526–30.
    OpenUrlCrossRef
  17. 17.↵
    1. Lingard EA,
    2. Katz JN,
    3. Wright EA,
    4. Sledge CB;
    5. the Kinemax Outcomes Group
    . Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am 2004;86:2179–86.
    OpenUrl
  18. 18.↵
    1. Goldsmith CH,
    2. Boers M,
    3. Bombardier C,
    4. Tugwell P
    . Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol 1993;20:561–5.
    OpenUrlPubMed
  19. 19.↵
    1. Leibs TR,
    2. Herzberg W,
    3. Roth-Krueger A,
    4. Ruther W,
    5. Hassenpflug J
    . Women recover faster than men after standard knee arthroplasty. Clin Orthop Relat Res 2011;469:2855–65.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Heiberg T,
    2. Kvien TK,
    3. Mowinckel P,
    4. Aletaha D,
    5. Smolen JS,
    6. Hagen KB
    . Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:967–71.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Jaeschke R,
    2. Singer J,
    3. Guyatt GH
    . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 1
1 Jan 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study
Jessica L. Maxwell, David T. Felson, Jingbo Niu, Barton Wise, Michael C. Nevitt, Jasvinder A. Singh, Laura Frey-Law, Tuhina Neogi
The Journal of Rheumatology Jan 2014, 41 (1) 60-64; DOI: 10.3899/jrheum.130313

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study
Jessica L. Maxwell, David T. Felson, Jingbo Niu, Barton Wise, Michael C. Nevitt, Jasvinder A. Singh, Laura Frey-Law, Tuhina Neogi
The Journal of Rheumatology Jan 2014, 41 (1) 60-64; DOI: 10.3899/jrheum.130313
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

KNEE REPLACEMENT
PHYSICAL FUNCTION
OUTCOMES

Related Articles

Cited By...

More in this TOC Section

  • Gut Microbiota as a Biomarker and Target in Biologic Therapy for Autoimmune and Immune-Mediated Arthritis: A Systematic Review
  • Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change
  • The Effect of Area-Level Socioeconomic Status on Disease Outcomes in Rheumatoid Arthritis: Results From an Australian Longitudinal Inception Cohort
Show more Article

Similar Articles

Keywords

  • KNEE REPLACEMENT
  • PHYSICAL FUNCTION
  • OUTCOMES

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire